Overall, 72% of 36,949 infants were immunized in the 2023-2024 RSV season with either the bivalent RSV prefusion F protein ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Respiratory syncytial virus (RSV) is a negative-stranded, RNA-based respiratory paramyxovirus with ten genes encoding 11 proteins. Three proteins are present in the viral envelope, including the ...

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a widespread yet lesser-known respiratory virus — and it is contagious. It transmits through inhalation or contact with respiratory ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults.

Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study. The research will be presented at ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a panel of experts advising the Centers for Disease Control and ...

A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV), meningitis and a mosquito-borne illness ...

Respiratory syncytial virus–related complications and healthcare costs among a Medicare-insured population in the United States. Open Forum Infectious Diseases, 10(5), ofad203. https://doi.org ...

RSV, or respiratory syncytial virus, is one of the leading causes of serious respiratory ill-health in the early years of one's life, and is usually prevalent during early winter months.

About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK ...